Coronary artery stents and non-cardiac surgery

被引:81
作者
Howard-Alpe, G. M.
de Bono, J.
Hudsmith, L.
Orr, W. P.
Foex, P.
Sear, J. W.
机构
[1] Univ Oxford, Nuffield Dept Anaesthet, John Radcliffe Hosp, Oxford OX3 9DU, England
[2] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England
[3] Royal Berkshire Hosp, Dept Cardiol, Reading RG1 5AN, Berks, England
关键词
anaesthetic techniques; regional; coronary stenosis; drug therapy; platelet aggregation inhibitors; therapeutic use; stents; surgery; non-cardiac;
D O I
10.1093/bja/aem089
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The utility of interventional cardiology has developed significantly over the last two decades with the introduction of coronary angioplasty and stenting, with the associated antiplatelet medications. Acute coronary stent occlusion carries a high morbidity and mortality, and the adoption of therapeutic strategies for prophylaxis against stent thrombosis has major implications for surgeons and anaesthetists involved in the management of these patients in the perioperative period. Currently, there is limited published information to guide the clinician in the optimal care of patients who have had coronary stents inserted when they present for non-cardiac surgery. This review examines the available literature on the perioperative management of these patients. A number of key issues are identified: the role of surgery vs percutaneous coronary intervention for coronary revascularization in the preoperative period; the different types of coronary stents currently available; the emerging issues related to drug-eluting stents; the pathophysiology of coronary stent occlusion; and the recommended antiplatelet regimes that the patient with a coronary stent will be receiving. The role of preoperative platelet function testing is also discussed, and the various available tests are listed. Appropriate management by all the clinicians involved with patients with coronary stents undergoing a variety of non-cardiac surgical procedures is essential to avoid a high incidence of postoperative cardiac mortality and morbidity. The review examines the evidence available for the perioperative strategies aimed at reducing adverse outcomes in a number of different clinical scenarios.
引用
收藏
页码:560 / 574
页数:15
相关论文
共 135 条
[1]   Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients - Insights from the Arterial Revascularization Therapy Study (ARTS) trial [J].
Abizaid, A ;
Costa, MA ;
Centemero, M ;
Abizaid, AS ;
Legrand, VMG ;
Limet, RV ;
Schuler, G ;
Mohr, FW ;
Lindeboom, W ;
Sousa, AGMR ;
Sousa, JE ;
van Hout, B ;
Hugenholtz, PG ;
Unger, F ;
Serruys, PW .
CIRCULATION, 2001, 104 (05) :533-538
[2]   Quantifying the effect of antiplatelet therapy -: A comparison of the platelet function Analyzer (PFA-100®) and modified thromboelastography (mTEG®) with lightt transmission platelet aggregometry [J].
Agarwal, Seema ;
Coakely, Margaret ;
Reddy, Kalpana ;
Riddell, Anne ;
Mallett, Susan .
ANESTHESIOLOGY, 2006, 105 (04) :676-683
[3]   Comparison of two strategies for the management of antiplatelet therapy during urgent surgery [J].
Akowuah, E ;
Shrivastava, V ;
Jamnadas, B ;
Hopkinson, D ;
Sarkar, P ;
Storey, R ;
Braidley, P ;
Cooper, G .
ANNALS OF THORACIC SURGERY, 2005, 80 (01) :149-152
[4]   Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force [J].
Albaladejo, P. ;
Marret, E. ;
Piriou, V. ;
Samama, C. -M. .
BRITISH JOURNAL OF ANAESTHESIA, 2006, 97 (04) :580-582
[5]  
Alderman EL, 1996, NEW ENGL J MED, V335, P217
[6]  
ALLEN JR, 1991, SURG GYNECOL OBSTET, V173, P285
[7]   High clopidogrel loading dose during coronary stenting:: effects on drug response and interindividual variability [J].
Angiolillo, DJ ;
Fernández-Ortiz, A ;
Bernardo, E ;
Ramírez, C ;
Sabaté, M ;
Bañuelos, C ;
Hernández-Antolín, R ;
Escaned, J ;
Moreno, R ;
Alfonso, F ;
Macaya, C .
EUROPEAN HEART JOURNAL, 2004, 25 (21) :1903-1910
[8]   In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution [J].
Ascione, R ;
Ghosh, A ;
Rogers, CA ;
Cohen, A ;
Monk, C ;
Angelini, GD .
ANNALS OF THORACIC SURGERY, 2005, 79 (04) :1210-1216
[9]   Risk of noncardiac surgery in the months following placement of a drug-eluting coronary stent [J].
Auer, J ;
Berent, R ;
Weber, T ;
Eber, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (04) :713-713
[10]   A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents [J].
Babapulle, MN ;
Joseph, L ;
Bélisle, P ;
Brophy, JM ;
Eisenberg, MJ .
LANCET, 2004, 364 (9434) :583-591